nalidixic acid has been researched along with Bone Marrow Diseases in 1 studies
Bone Marrow Diseases: Diseases involving the BONE MARROW.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study whether oral ciprofloxacin would be as effective in preventing bacterial infections in severely myelosuppressed patients as selective antibiotic modulation of the gut flora with neomycin/polymyxin B sulfate/nalidixic acid (NPN)." | 5.07 | Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora. ( Akard, L; Allen, SD; Black, JR; Cromer, M; Jansen, J; Wheat, LJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jansen, J | 1 |
| Cromer, M | 1 |
| Akard, L | 1 |
| Black, JR | 1 |
| Wheat, LJ | 1 |
| Allen, SD | 1 |
1 trial available for nalidixic acid and Bone Marrow Diseases
| Article | Year |
|---|---|
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bone Marrow Diseases; Ciprofloxacin; Drug Therapy, Co | 1994 |